SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
|
CN |
|
Carawine Resources Ltd
ASX:CWX
|
AU |
|
T
|
ThredUp Inc
NASDAQ:TDUP
|
US |
|
Curves Holdings Co Ltd
TSE:7085
|
JP |
|
MedPeer Inc
TSE:6095
|
JP |
|
First Sponsor Group Ltd
SGX:ADN
|
SG |
|
A
|
Asgent Inc
TSE:4288
|
JP |
|
C
|
Core Molding Technologies Inc
F:XQN
|
US |
|
Bank Jago Tbk PT
IDX:ARTO
|
ID |
|
Aguia Resources Ltd
ASX:AGR
|
AU |
|
S
|
Swiss Properties Invest A/S
CSE:SWISS
|
DK |
|
MCC Meili Cloud Computing Industry Investment Co Ltd
SZSE:000815
|
CN |
|
ANK Bashneft' PAO
MOEX:BANE
|
RU |
|
H
|
HMM Co Ltd
KRX:011200
|
KR |
|
Defentect Group Inc
OTC:DFTC
|
US |
|
B
|
Bank Leumi Le Israel BM
TASE:LUMI
|
IL |
Bankruptcy Probability
SciClone Pharmaceuticals (Holdings) Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
SciClone Pharmaceuticals (Holdings) Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
S
|
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
|
22.2B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
875.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
SciClone Pharmaceuticals (Holdings) Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, SciClone Pharmaceuticals (Holdings) Ltd has total debt of 19.8m CNY. This includes both short-term (0 CNY) and long-term (19.8m CNY) debt.
You can find a full breakdown on its Balance Sheet.
